Large-scale testing (Phase 3)Study completedNCT01214837
What this trial is testing
Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life
Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 751